Vanderbilt Vaccine Center Archives
Initiative seeks to develop therapies to combat Ebola
Sep. 18, 2014—Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.
Vanderbilt Vaccine Center joins global task force to address urgent viral threat
Apr. 7, 2014—World Health Day 2014 Shines Spotlight on Mosquito-borne Viral Diseases Chikungunya virus, a vector-borne disease that is quickly spread by mosquitoes and causes victims to suffer severe fever and pain, has reached the Caribbean and South America—and is predicted to soon cause outbreaks in the United States. For many years the virus has remained primarily...
Multi-center effort targets lethal Ebola, Marburg viruses
Mar. 6, 2014—Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections.
Nine faculty honored with endowed chairs
Jan. 24, 2014—Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.
VUCast: Preventing the next pandemic
Sep. 18, 2013—Researchers work to prevent possible bird flu pandemic How stars solve mysteries of the universe And conquering the video gaming industry Vandy style? All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now.
Controversial info release aids VUMC bird flu research
Sep. 5, 2013—Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin.
VU researchers ‘goldsmith’ new RSV vaccine approach
Jul. 18, 2013—Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.
Grant targets new therapies for Ebola, Marburg viruses
May. 16, 2013—Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.
Structural snapshot hints at new influenza approach
Feb. 21, 2013—A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.
Repository samples help shape view of new rhinovirus
Dec. 6, 2012—Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades.
VUMC researchers reveal darker side of common cold
Jan. 5, 2012—Human rhinovirus (HRV), also known as the common cold, can be uncommonly serious for certain children, a study led by a Vanderbilt University Medical Center pediatrician shows. The study, published in the Dec. 28, 2011 online issue of the journal Pediatrics, shows that not only can HRV lead to hospitalization in very low birth weight...
